Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance

W Wu, JL Klockow, M Zhang, F Lafortune… - Pharmacological …, 2021 - Elsevier
Glioblastoma multiforme (GBM) is a WHO grade IV glioma and the most common malignant,
primary brain tumor with a 5-year survival of 7.2%. Its highly infiltrative nature, genetic …

Prostate MRI, with or without MRI‐targeted biopsy, and systematic biopsy for detecting prostate cancer

FJH Drost, DF Osses, D Nieboer… - Cochrane Database …, 2019 - cochranelibrary.com
Background Multiparametric magnetic resonance imaging (MRI), with or without MRI‐
targeted biopsy, is an alternative test to systematic transrectal ultrasonography‐guided …

Multiparametric MRI for prostate cancer diagnosis: current status and future directions

A Stabile, F Giganti, AB Rosenkrantz, SS Taneja… - Nature reviews …, 2020 - nature.com
The current diagnostic pathway for prostate cancer has resulted in overdiagnosis and
consequent overtreatment as well as underdiagnosis and missed diagnoses in many men …

EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent

N Mottet, J Bellmunt, M Bolla, E Briers… - European urology, 2017 - Elsevier
Objective To present a summary of the 2016 version of the European Association of Urology
(EAU)-European Society for Radiotherapy & Oncology (ESTRO)-International Society of …

Prostate magnetic resonance imaging, with or without magnetic resonance imaging-targeted biopsy, and systematic biopsy for detecting prostate cancer: a Cochrane …

FJH Drost, D Osses, D Nieboer, CH Bangma… - European urology, 2020 - Elsevier
Context Magnetic resonance imaging (MRI), with or without MRI-targeted biopsy (MRI
pathway), is an alternative test to systematic transrectal ultrasonography-guided biopsy in …

Comparison of multiparametric magnetic resonance imaging–targeted biopsy with systematic transrectal ultrasonography biopsy for biopsy-naive men at risk for …

L Klotz, J Chin, PC Black, A Finelli, M Anidjar… - JAMA …, 2021 - jamanetwork.com
Importance Magnetic resonance imaging (MRI) with targeted biopsy is an appealing
alternative to systematic 12-core transrectal ultrasonography (TRUS) biopsy for prostate …

Comparing three different techniques for magnetic resonance imaging-targeted prostate biopsies: a systematic review of in-bore versus magnetic resonance imaging …

O Wegelin, HHE van Melick, L Hooft, JLHR Bosch… - European urology, 2017 - Elsevier
Context The introduction of magnetic resonance imaging-guided biopsies (MRI-GB) has
changed the paradigm concerning prostate biopsies. Three techniques of MRI-GB are …

Accuracy of magnetic resonance imaging for local staging of prostate cancer: a diagnostic meta-analysis

M de Rooij, EHJ Hamoen, JA Witjes, JO Barentsz… - European urology, 2016 - Elsevier
Context Correct assessment of tumour stage is crucial for prostate cancer (PCa)
management. Objective To assess the diagnostic accuracy of magnetic resonance imaging …

The FUTURE trial: a multicenter randomised controlled trial on target biopsy techniques based on magnetic resonance imaging in the diagnosis of prostate cancer in …

O Wegelin, L Exterkate, M van der Leest, JA Kummer… - European urology, 2019 - Elsevier
Background Guidelines advise multiparametric magnetic resonance imaging (mpMRI)
before repeat biopsy in patients with negative systematic biopsy (SB) and a suspicion of …

Magnetic resonance imaging–targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal …

IG Schoots, MJ Roobol, D Nieboer, CH Bangma… - European urology, 2015 - Elsevier
Context Multiparametric magnetic resonance imaging (MRI) of the prostate may improve the
diagnostic accuracy of prostate cancer detection in MRI-targeted biopsy (MRI-TBx) in …